|
Guangzhou Dreampharm Biotechnology Co., Ltd.
|
Founded in 2014, Guangzhou Junmu Biotechnology Co., Ltd. is a high-tech enterprise integrating pharmaceutical research and development, biotechnology services (raw and auxiliary material production) and marketing; The company strictly follows the ISO9001 and CNAS management system for product quality management, and passed the on-site inspection of the China Institute for Food and Drug Control in 2019 and officially became a supplier of reference materials and raw materials.
Please contact customer service for the specific transaction price to confirm, contact information: 13502246435" |
Send Inquiry
|
|
ZHEJIANG SACHEM PHARMACEUTICAL TECHNOLOGY CO.,LTD.
|
Since its establishment, Zhejiang Saikai Pharmaceutical Technology Co., Ltd. has continuously enhanced its resource integration ability around the pharmaceutical industry chain, built an enterprise-oriented and market-oriented business system, actively identified the key links of the upstream and downstream of the industrial chain, and promoted the overall improvement of the supply chain.
The company has always been committed to opening the international market for small and medium-sized production enterprises. Through the efforts of professional international business team, the company has helped steroid hormone apis and intermediates gain a certain market voice in India. Based on the existing achievements, the company insists on expanding the product line, and has established cooperative relations with many manufacturers in Zhejiang, Hunan, Jiangsu and other provinces. In addition to India, the products are exported to Europe, South America and other overseas regions, and a broad sales market has been established.
Since 2059, relying on the head office to carry out API import, registration and agent procurement business. Under the cooperation of the total company registration team, the company successfully completed the introduction and registration of a number of high-quality apis, and established product cooperation with foreign first-line enterprises, and successfully helped the parent company and domestic pharmaceutical customers related review.
In the future, Sikai Pharmaceutical will forge ahead, do not slack, focus on improving the level of business, to create an excellent corporate brand image. We will make full use of our own advantages, continue to integrate domestic and foreign resources, through strategic cooperation to reach a strong alliance between enterprises, to achieve mutual benefit, mutual assistance and win-win. |
Send Inquiry
|
Pharma Sources Insight June 2024: Globalization on the Go
